During the diagnosis of NSCLC, the combined application of ALDH1A1 and carcinoembryonic antigen can significantly increase the sensitivity, compared to that observed with the use of carcinoembryonic antigen alone (26). The gene discussed is ALDH1A1; the disease is non-small cell lung carcinoma.